Search

Your search keyword '"Doolan DL"' showing total 203 results

Search Constraints

Start Over You searched for: Author "Doolan DL" Remove constraint Author: "Doolan DL"
203 results on '"Doolan DL"'

Search Results

1. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses

2. A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission Setting

3. Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features

4. A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2

5. Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype

6. IgM in human immunity to Plasmodium falciparum malaria

7. Plasmodium vivax but Not Plasmodium falciparum Blood-Stage Infection in Humans Is Associated with the Expansion of a CD8+ T Cell Population with Cytotoxic Potential

8. Of monkeys and men: immunomic profiling of sera from humans and non-human primates resistant to schistosomiasis reveals novel potential vaccine candidates

9. The Role of Age and Exposure to Plasmodium falciparum in the Rate of Acquisition of Naturally Acquired Immunity: A Randomized Controlled Trial

10. Bacterial Antigen Expression Is an Important Component in Inducing an Immune Response to Orally Administered Salmonella-Delivered DNA Vaccines

11. A proteome-wide analysis unveils a core Epstein-Barr virus antibody signature of classic Hodgkin lymphoma across ethnically diverse populations.

12. Differential EBV protein-specific antibody response between responders and non-responders to EBVSTs immunotherapy.

13. Technical pitfalls when collecting, cryopreserving, thawing, and stimulating human T-cells.

14. Evaluating the stability of host-reference gene expression and simultaneously quantifying parasite burden and host immune responses in murine malaria.

15. Small extracellular vesicles but not microvesicles from Opisthorchis viverrini promote cell proliferation in human cholangiocytes.

16. Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies.

17. Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regions.

18. Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial disease.

19. The Effect of Tropical Temperatures on the Quality of RNA Extracted from Stabilized Whole-Blood Samples.

20. Novel antiinflammatory biologics shaped by parasite-host coevolution.

21. A high-throughput screening RT-qPCR assay for quantifying surrogate markers of immunity from PBMCs.

22. CD161 expression defines new human γδ T cell subsets.

23. Proteomic identification of the contents of small extracellular vesicles from in vivo Plasmodium yoelii infection.

24. Estimating the global burden of Epstein-Barr virus-related cancers.

25. Identifying Epstein-Barr virus peptide sequences associated with differential IgG antibody response.

26. Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma.

27. A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2.

28. Malaria research in Australia: looking through the lens of the past towards the future.

29. Editorial: Coronavirus Disease (COVID-19): Pathophysiology, Epidemiology, Clinical Management and Public Health Response.

30. Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification study.

31. Identification of the Glycan Binding Profile of Human and Rodent Plasmodium Sporozoites.

32. CD8 + T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity.

33. Systems serology detects functionally distinct coronavirus antibody features in children and elderly.

34. Memory CD8 + T cell compartment associated with delayed onset of Plasmodium falciparum infection and better parasite control in sickle-cell trait children.

35. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses.

36. Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features.

37. A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission Setting.

38. A population of CD4 hi CD38 hi T cells correlates with disease severity in patients with acute malaria.

39. Chimeric Virus-Like Particles and Capsomeres Induce Similar CD8 + T Cell Responses but Differ in Capacity to Induce CD4 + T Cell Responses and Antibody Responses.

40. Suboptimal SARS-CoV-2-specific CD8 + T cell response associated with the prominent HLA-A*02:01 phenotype.

41. Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma.

42. Uptake of Schistosoma mansoni extracellular vesicles by human endothelial and monocytic cell lines and impact on vascular endothelial cell gene expression.

44. Development and validation of serological markers for detecting recent Plasmodium vivax infection.

45. Validation of an Epstein-Barr Virus Antibody Risk Stratification Signature for Nasopharyngeal Carcinoma by Use of Multiplex Serology.

46. A novel population of memory-activated natural killer cells associated with low parasitaemia in Plasmodium falciparum -exposed sickle-cell trait children.

47. An Analytically and Diagnostically Sensitive RNA Extraction and RT-qPCR Protocol for Peripheral Blood Mononuclear Cells.

48. The Rise of Non-Tuberculosis Mycobacterial Lung Disease.

49. Immune Signature Against Plasmodium falciparum Antigens Predicts Clinical Immunity in Distinct Malaria Endemic Communities.

50. Deciphering host immunity to malaria using systems immunology.

Catalog

Books, media, physical & digital resources